• Latest Posts

The challenges of translating CRISPR to the clinic

CRISPR/Cas9: Challenges and outlook from an investor’s perspective

More News! 14 Oct 2022

ChristianaCare spins out new gene-editing company CorriXR Therapeutics

Cytel signs agreement with two Scandinavian medicinal product companies

Beyond Biotech podcast 18: BiotechX, Cultivated Biosciences, EPFL, Faron Pharmaceuticals

Danish researchers create ‘Wikipedia of resistant bacteria’

ADVERTISEMENT

Mablink Bioscience receives €31M series A funding for ADC pipeline 

A-Alpha Bio and Bristol Myers Squibb to collaborate on protein degradation

Plan launched to improve diversity of clinical trials

Agreement to take advantage of stem cells from first teeth

CMT Research Foundation funding boosts Samsara Therapeutics Charcot-Marie-Tooth treatment

Xcell Biosciences and aCGT Vector pushing ahead with cell and gene therapies

ADVERTISEMENT